Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions ; volume:15 ; number:1 ; day:5 ; month:3 ; year:2024 ; pages:1-15 ; date:12.2024
Stem cell research & therapy ; 15, Heft 1 (5.3.2024), 1-15, 12.2024
- Urheber
-
Herger, Nick
Heggli, Irina
Mengis, Tamara
Devan, Jan
Arpesella, Leonardo
Brunner, Florian
Distler, Oliver
Dudli, Stefan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-024-03677-5
- URN
-
urn:nbn:de:101:1-2405101050224.350646014103
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Herger, Nick
- Heggli, Irina
- Mengis, Tamara
- Devan, Jan
- Arpesella, Leonardo
- Brunner, Florian
- Distler, Oliver
- Dudli, Stefan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enhancement of immunosuppressive activity of mesenchymal stromal cells by platelet-derived factors is accompanied by apoptotic priming
Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
![Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids
Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
Enhancement of immunosuppressive activity of mesenchymal stromal cells by platelet-derived factors is accompanied by apoptotic priming
Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids
Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
Enhancement of immunosuppressive activity of mesenchymal stromal cells by platelet-derived factors is accompanied by apoptotic priming
Enhancement of Immunosuppressive Activity of Mesenchymal Stromal Cells by Platelet-Derived Factors is Accompanied by Apoptotic Priming
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Effect of immunosuppressive drugs on immunomodulatory properties of human mesenhymal [mesenchymal] stromal cells
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells
Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids
Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1/STAT3 and P38 signals
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies